Passive

Invesco Dorsey Wright Healthcare Momentum ETF

The Invesco Dorsey Wright Healthcare Momentum ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical LeadersTM Index (the “Underlying Index”).

$40.51

+14.4% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Dorsey Wright Healthcare Momentum ETF PTH
Fund Size
$175 Million
Dividend
0.0%
Fees
0.60%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.3%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.3%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $19.8 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.07 %
Beta Indicates the relationship between the price performance of a share and the market. 0.8823
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 73.02
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -19.5
Profitable Companies 41
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 407.28
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.37
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company -0.67
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 26.0
Enterprise Value to Revenue Enterprise value divided by revenue 25.93
Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -3.7312
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -90.53%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 24.20%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.25%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -2.37%

Industries

Healthcare 83.9%
Finance 4.8%
Other 1.6%
N/A 9.7%

Market cap

Micro Cap 11%
Small Cap 22%
Mid Cap 43%
Large Cap 20%
Mega Cap 4%

62 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$30.2 Million
Weight
22.8%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$11.8 Million
Weight
8.9%
Eli Lilly and Co. logo

LLY - Manufacturing

Eli Lilly and Co.

P/E-Ratio
137.7
Total Investment
$6.59 Million
Weight
5.0%
UnitedHealth Group Inc. logo

UNH - Finance and Insurance

UnitedHealth Group Inc.

P/E-Ratio
18.2
Total Investment
$6.05 Million
Weight
4.6%
IDEXX Laboratories, Inc. logo

IDXX - Manufacturing

IDEXX Laboratories, Inc.

P/E-Ratio
49.4
Total Investment
$5.35 Million
Weight
4.0%
Ardelyx, Inc. logo

ARDX - Manufacturing

Ardelyx, Inc.

P/E-Ratio
0.0
Total Investment
$4.26 Million
Weight
3.2%
Medpace Holdings, Inc. logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings, Inc.

P/E-Ratio
44.1
Total Investment
$4.04 Million
Weight
3.0%
C4 Therapeutics, Inc. logo

CCCC - Manufacturing

C4 Therapeutics, Inc.

P/E-Ratio
-4.0
Total Investment
$3.66 Million
Weight
2.8%
IDEAYA Biosciences, Inc. logo

IDYA - Professional, Scientific, and Technical Services

IDEAYA Biosciences, Inc.

P/E-Ratio
-28.7
Total Investment
$3.66 Million
Weight
2.8%
CymaBay Therapeutics, Inc. logo

CBAY - Manufacturing

CymaBay Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$3.5 Million
Weight
2.6%
Biohaven Ltd. logo

BHVN - Manufacturing

Biohaven Ltd.

P/E-Ratio
0.0
Total Investment
$3.48 Million
Weight
2.6%
EyePoint Pharmaceuticals, Inc. logo

EYPT - Manufacturing

EyePoint Pharmaceuticals, Inc.

P/E-Ratio
0.0
Total Investment
$3.38 Million
Weight
2.5%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
25.1
Total Investment
$3.38 Million
Weight
2.5%
Tenet Healthcare Corp. logo

THC - Health Care and Social Assistance

Tenet Healthcare Corp.

P/E-Ratio
16.7
Total Investment
$3.27 Million
Weight
2.5%
RxSight, Inc. logo

RXST - Manufacturing

RxSight, Inc.

P/E-Ratio
0.0
Total Investment
$3.25 Million
Weight
2.4%
Molina Healthcare, Inc. logo

MOH - Finance and Insurance

Molina Healthcare, Inc.

P/E-Ratio
20.2
Total Investment
$3.22 Million
Weight
2.4%
Cabaletta Bio, Inc. logo

CABA - Professional, Scientific, and Technical Services

Cabaletta Bio, Inc.

P/E-Ratio
0.0
Total Investment
$3.21 Million
Weight
2.4%
Altimmune, Inc. logo

ALT - Manufacturing

Altimmune, Inc.

P/E-Ratio
0.0
Total Investment
$3.01 Million
Weight
2.3%
MoonLake Immunotherapeutics logo

MLTX

MoonLake Immunotherapeutics

P/E-Ratio
0.0
Total Investment
$2.92 Million
Weight
2.2%
Elanco Animal Health Inc. logo

ELAN - Manufacturing

Elanco Animal Health Inc.

P/E-Ratio
-5.9
Total Investment
$2.76 Million
Weight
2.1%
DexCom, Inc. logo

DXCM - Manufacturing

DexCom, Inc.

P/E-Ratio
99.4
Total Investment
$2.66 Million
Weight
2.0%
Vera Therapeutics, Inc. logo

VERA - Professional, Scientific, and Technical Services

Vera Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$2.57 Million
Weight
1.9%
ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

P/E-Ratio
n/a
Total Investment
$2.26 Million
Weight
1.7%
Amphastar Pharmaceuticals, Inc. logo

AMPH - Manufacturing

Amphastar Pharmaceuticals, Inc.

P/E-Ratio
14.0
Total Investment
$2.14 Million
Weight
1.6%
Nuvalent, Inc. logo

NUVL - Professional, Scientific, and Technical Services

Nuvalent, Inc.

P/E-Ratio
0.0
Total Investment
$2.07 Million
Weight
1.6%